NEW YORK (GenomeWeb News) – Bruker reported today that its revenues in the third quarter were down 6 percent year over year, falling to $396.1 million from $419.8 million in Q3 2014 but beating analysts' consensus estimate of $373.7 million.

Excluding a 3 percent negative effect from divestitures and an 11 percent negative effect from currency exchange rates, the company posted Q3 organic growth of 8 percent. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.

Oct
10
Sponsored by
PerkinElmer

This online, interactive seminar will answer researchers’ most pressing questions about how to gain outstanding research results from proteomic studies.